Health ❯ Nutrition ❯ Dietary Supplements
Lifestyle Changes Semaglutide Obesity Treatments GLP-1 Drugs Medication Effects Oral Medications Celebrity Influence Medication Obesity Exercise and Libido Alternative Therapies Injection Therapies Natural Ingredients Clinical Trials GLP-1 Medications Oral Weight-Loss Pills Appetite Control Pharmaceuticals Exercise and Diet Genetic Factors Dietary Medications Behavioral Programs Long-term Weight Loss Patient Care GLP-1 Agonists Clinical Guidelines Lean Body Mass Caloric Deficit Protein Products Caloric Intake Injectable Treatments Pills Caloric Restriction Thermogenesis Side Effects Pharmaceutical Innovations Weight Loss Medications Weight Loss Injections Orforglipron Effects Exercise and Physical Activity Clinical Support Consumer Trends
Early phase 2 results show the drug kept about half of lost lean mass without reducing overall weight loss; larger and longer trials are needed before it could be used in patients.
